Lee Golden, M.D., joins RHI with more than 19 years in the Pharmaceutical and Biotech industries. He is currently the Head of Global Clinical Development at PTC Therapeutics, Inc and Chairman of the Board at Coagulation Science LLC. Dr. Golden first began his career at Pfizer Pharmaceuticals as a Medical Director. He then served in various senior leadership positions at Novartis Pharmaceuticals Corp., Elan Pharmaceuticals Inc., and Actelion Pharmaceuticals US, Inc. He also worked as Global Head of Cardiovascular and Hematology at Eisai Inc., where he led global research and development from discovery through approval. In 2011, Dr. Golden became Senior Vice President and Therapeutic Area Head at Mesoblast Inc. In 2016, he became Chief Medical Officer for Gemphire Therapeutics and was CMO at Espero BioPharma just prior to his current role. Dr. Golden received his M.D. from the New York University School of Medicine and his B.S. from the University of Michigan.